Sharad Mansukani Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month ago
Sharad Mansukani has an estimated net worth of at least $11.7 million*, as of April 16, 2025. They own 1.3 million shares of AGL stock. They have sold 156,250 shares of AGL stock since 2021, for an estimated $4.5 million.
Sharad Mansukani $AGL SEC Form 4 Insider Trading
Sharad Mansukani has filed a total of 1 insider trades in $AGL since 2021. Their most recent trade was a sale of 156,250 shares, made on Sep 14, 2021. Their largest trade was a sale of 156,250 shares, made on Sep 14, 2021. We estimate that they now own 1.3 million shares of $AGL, worth an estimated $7.2 million.
Insider Trading at $AGL
There have been a total of 160 insider trades reported at $AGL since 2021, with 536,127 shares purchased and 127.2 million shares sold. The most active insider traders in $AGL stock have been Benjamin Kornitzer, Benjamin Shaker, and Veeral Desai. The most recent trade was a purchase of 42,426 shares reported by Steven Sell (CEO & President), made on Mar 14, 2025.
History of Insider Stock Trades by Sharad Mansukani
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 156,250 | Sep 14, 2021 | Sept. 14, 2021, 8 p.m. |
$AGL Executives and Stock Owners with Insider Trades
-
Benjamin Kornitzer, Chief Med. & Quality Officer
-
Benjamin Shaker, Chief Markets Officer
-
Veeral Desai, Chief Strategy & Dev. Officer
-
Theodore Halkias, Chief Business Officer
-
Joan Danieley, Chief Administrative Officer
-
Steven Sell, CEO & President
-
Girish Venkatachaliah, Chief Technology Officer
-
Timothy Gertsch, Chief Accounting Officer
-
Glenn Sobotka, Chief Accounting Officer
-
Lisa Dombro, Exper. & Innovation Officer
-
Timothy Bensley, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.